Cargando…
TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis
Aberrant activation of nuclear factor-κB (NF-κB) allows cancer cells to escape chemotherapy-induced cell death and acts as one of the major mechanisms of acquired chemoresistance in cervical cancer. TAK1, a crucial mediator that upregulates NF-κB activation in response to cellular genotoxic stress,...
Autores principales: | Guan, Shan, Lu, Jiaxiong, Zhao, Yanling, Woodfield, Sarah E., Zhang, Huiyuan, Xu, Xin, Yu, Yang, Zhao, Jing, Bieerkehazhi, Shayahati, Liang, Haoqian, Yang, Jianhua, Zhang, Fuchun, Sun, Surong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464900/ https://www.ncbi.nlm.nih.gov/pubmed/28430599 http://dx.doi.org/10.18632/oncotarget.16895 |
Ejemplares similares
-
MELK is a novel therapeutic target in high-risk neuroblastoma
por: Guan, Shan, et al.
Publicado: (2017) -
Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells
por: Shi, Yonghua, et al.
Publicado: (2016) -
TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells
por: Wang, Zhenyu, et al.
Publicado: (2016) -
Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis
por: Guan, Shan, et al.
Publicado: (2016) -
Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma
por: Mao, Xinfang, et al.
Publicado: (2016)